当前位置:首页 - 行情中心 - 亨迪药业(301211) - 财务分析 - 现金流量表

亨迪药业

(301211)

  

流通市值:46.39亿  总市值:46.40亿
流通股本:4.18亿   总股本:4.18亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金88,459,233.81374,834,722.08288,873,181.83191,151,557.64
  收到的税费返还2,196,989.18,338,284.745,229,831.994,374,044.84
  收到其他与经营活动有关的现金20,944,057.5523,615,243.5919,827,594.0313,668,096.59
  经营活动现金流入小计111,600,280.46406,788,250.41313,930,607.85209,193,699.07
  购买商品、接受劳务支付的现金44,442,656.76206,998,897.33139,589,751.4197,977,511.01
  支付给职工以及为职工支付的现金31,215,673.86108,119,795.6881,275,619.3856,859,276.71
  支付的各项税费3,374,444.3917,011,897.4715,247,522.328,633,736.76
  支付其他与经营活动有关的现金35,030,319.4567,106,840.4758,947,376.737,321,880.36
  经营活动现金流出小计114,063,094.46399,237,430.95295,060,269.81200,792,404.84
  经营活动产生的现金流量净额-2,462,8147,550,819.4618,870,338.048,401,294.23
二、投资活动产生的现金流量:
  收回投资收到的现金-474,955,491.68174,284,491.68144,284,491.68
  取得投资收益收到的现金-15,762,324.964,720,661.413,617,244.74
  处置固定资产、无形资产和其他长期资产收回的现金净额-31,51536,170.6711,870.67
  投资活动现金流入的平衡项目-000
  投资活动现金流入小计-490,749,331.64179,041,323.76147,913,607.09
  购建固定资产、无形资产和其他长期资产支付的现金19,186,893.0652,329,363.8442,293,706.4525,658,235.03
  投资支付的现金-475,707,930.0890,000,00070,000,000
  投资活动现金流出小计19,186,893.06528,037,293.92132,293,706.4595,658,235.03
  投资活动产生的现金流量净额-19,186,893.06-37,287,962.2846,747,617.3152,255,372.06
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金-72,000,00072,000,00072,000,000
  支付其他与筹资活动有关的现金-1,402,643.11815,730.94815,730.94
  筹资活动现金流出平衡项目-000
  筹资活动现金流出小计-73,402,643.1172,815,730.9472,815,730.94
  筹资活动产生的现金流量净额平衡项目-000
  筹资活动产生的现金流量净额--73,402,643.11-72,815,730.94-72,815,730.94
四、汇率变动对现金及现金等价物的影响-725,827.95-1,141,506.19-120,532.69388,707.74
五、现金及现金等价物净增加额-22,375,535.01-104,281,292.12-7,318,308.28-11,770,356.91
  加:期初现金及现金等价物余额447,658,499.51543,039,791.63543,139,791.63543,039,791.63
  期末现金及现金等价物余额425,282,964.5438,758,499.51535,821,483.35531,269,434.72
补充资料:
  净利润-34,910,598.79-18,547,082.58
  资产减值准备-4,346,634.5-2,029,344.38
  固定资产和投资性房地产折旧-40,080,521.37-20,787,354.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-40,080,521.37-20,787,354.9
  无形资产摊销-2,113,037.64-1,056,518.82
  长期待摊费用摊销-285,693.36-142,846.68
  处置固定资产、无形资产和其他长期资产的损失--11,870.67--11,870.67
  固定资产报废损失-17,007.64-18,897.11
  公允价值变动损失--12,969,750.06--10,571,513.92
  财务费用-1,320,552.89-64,974.01
  投资损失--16,165,741.61--4,282,814.18
  递延所得税-781,086.19-1,449,458.22
  其中:递延所得税资产减少--370,529.73--139,856.93
    递延所得税负债增加-1,151,615.92-1,589,315.15
  存货的减少-10,827,036.32-19,925,750.84
  经营性应收项目的减少--14,141,118.35-4,140,523.69
  经营性应付项目的增加--45,256,325.83--46,321,665.56
  现金的期末余额-438,758,499.51-531,269,434.72
  减:现金的期初余额-543,039,791.63-543,039,791.63
  现金及现金等价物的净增加额--104,281,292.12--11,770,356.91
公告日期2026-04-232026-03-312025-10-282025-08-01
审计意见(境内)标准无保留意见标准无保留意见
TOP↑